Profile data is unavailable for this security.
About the company
WntResearch AB is a Sweden-based company engaged in the translational cancer research. Its aim is to develop anti-metastatic therapies based on an increased understanding of the mechanisms underlying the metastatic process and the evaluation of specific small molecules that can specifically interact with this process. The Company’s programs focus on the role of the Wnt-5a protein in the metastatic process. As of December 31, 2011, the Company had two projects, namely Foxy-5 and Box-5. Foxy-5 is a hexapeptide mimicking the effects of WNT-5a. Box-5 is a peptide antagonizing the effects of Wnt-5a. As of March 31, 2012, the Company’s largest shareholder was Forskarpatent I Syd AB, which held 26.55% shares.
- Revenue in SEK (TTM)0.00
- Net income in SEK-35.82m
- Incorporated2007
- Employees2.00
- LocationWntresearch ABc/o Er Redovisning, Stora Sodergatan 15LUND 222 23SwedenSWE
- Phone+46 40321022
- Websitehttps://www.wntresearch.com/